What is Abuse‑Deterrent Technology(ADT)

Abuse‑Deterrent Technology (ADT) refers to a range of formulation strategies designed to minimize the risk of misuse or abuse of controlled medications, while maintaining their therapeutic effectiveness. ADT formulations use physical, chemical, or combination-based barriers to resist tampering, crushing, dissolving, or extracting active ingredients for non-prescribed use.

These technologies are critical in helping ensure patient safety, supporting healthcare providers, and aligning with global regulatory guidance for controlled substances.

Why ADT Matters

01

Enhanced Patient Safety

The technology allows manipulation of multiple variables (polymer type, matrix density, coating parameters), enabling custom release profiles tailored to drug chemistry and therapeutic needs.

02

Regulatory Alignment

Reduces the potential for misuse through tampering, extraction, or alternative routes of administration.

03

Maintains Therapeutic Performance

Designed to deliver the intended drug effect while discouraging misuse.

04

Supports Responsible Prescribing

Helps healthcare professionals mitigate risks associated with controlled substances.

Typical Use Cases & Therapeutic Areas

ADT is particularly valuable for medications where abuse or misuse risk is high, including:

Controlled-Release Pain Relief

Opioids and analgesics requiring controlled release.

High-Risk Medication Safety

CNS agents or other high-risk medications.

Compliance & Safety Focus

Controlled-release drugs where patient safety and compliance are critical.

Generic & Novel Applications

Products developed for both generic conversions and novel formulations requiring regulatory approval.

At Medicap Labs, our ADT offering includes:

Formulation Development

Formulation Design & Development strategies tailored using physical, chemical, or combined deterrent mechanisms.

Regulatory Support

Regulatory support for both ANDA (generic) and NDA (505(b)(2) or novel) pathways

Release Customization

Flexible tailoring of release profiles based on API properties and therapeutic targets

Scale-Up

Scale-up and GMP-compliant production capabilities ensuring reliable transition from lab to commercial batches

Interested in exploring how Abuse Deterrent Technology can meet your development needs? Reach out to our team to discuss your API, target release profile, and regulatory strategy.

Get Started